White label – Pompe disease - ClinicalTrials.eu

Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

Not recruiting

1 1 1 1
Investigated Drugs:
- Nivolumab
Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Not recruiting

3 1
Investigated Drugs:
- Astegolimab
+10
Comparing inavolisib plus fulvestrant versus alpelisib plus fulvestrant in patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on Cladribine for Patients with Multiple Sclerosis to Evaluate Brain Network Changes

Not recruiting

3 1 1 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Cladribine
Study on Oxygen Levels for Children and Adolescents with Respiratory Distress: Focusing on Bronchiolitis, Viral Wheeze, and Lower Respiratory Tract Infection

Not recruiting

3 1 1 1
Investigated Drugs:
- Oxygen
Study on the Effects of ABBV-552 in Patients Aged 50-90 with Mild Alzheimer’s Disease

Not recruiting

2 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- (4R)-1-[(5-Chloro-1H-1,2,4-Triazol-1-Yl)Methyl]-4-(3,4,5-Trifluorophenyl)-2-Pyrrolidinone
Study on Patiromer and Placebo for Managing Hyperkalemia in Non-Dialysis Patients with Chronic Kidney Disease Stages IIIB to V

Not recruiting

3 1 1
Investigated Diseases:
- Hyperkalaemia
Investigated Drugs:
Study on the Effectiveness of Mistletoe Extract and Mitomycin in Patients with Superficial Bladder Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
- Extract Of Fresh Ash Mistletoe Herb
- Mitomycin
Study on Early vs. Delayed Supplementary Parenteral Nutrition with SmofKabiven for Patients After Major Emergency Abdominal Surgery

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

Not recruiting

3 1 1
Investigated Drugs:
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies